Top Markets
#1 Cortex Cortex +32.71%
#2 EXOD EXOD +9.04%
#3 Seeker Seeker +8.43%
#4 ETHGas ETHGas +7.85%
#5 MarsCoin MarsCoin +7.84%
#6 peaq peaq +7.74%
#7 Official Trump Official Trump +6.67%
#8 Solstice Solstice +5.96%
#9 Ethena Staked ENA Ethena Staked ENA +5.92%
#10 DexNet DexNet +5.76%
Coin of the day
Cortex Cortex
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Hisse Senetlerindeki Sıralama #6696
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Hisse Fiyatı
$30.90
Son senkronizasyon: 2026-08-27
Piyasa Değeri
$1.90B
Değişim (1 gün)
1.68%
Değişim (1 yıl)
859.63%
Ülke
US
Ticaret Damora Therapeutics, Inc. (DMRA)

Kategori

Healthcare
Damora Therapeutics, Inc. (DMRA) için temettü verimi geçmişi
Damora Therapeutics, Inc. (hisse sembolü: DMRA) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
Damora Therapeutics, Inc. (DMRA) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)
Şirket Temettü Verimi Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH